Abstract:Abstract Background and Aims The fatty acid binding proteins family of lipid chaperones (FABPs) mediate lipid trafficking and lipid-mediated metabolic pathways. Despite inhibition of induced FABPs may be beneficial in kidney damage, their enrolment in renal metabolic homeostasis remains elusive. Therefore, we approached this issue in cultured renal tubular cells. Method FABP mRNA and protein expression were evaluated in C57/BL6 mice subjected to folic-acid kidney injury. Mitochondrial redox status, proliferation, death rate, and fatty acid oxidation (FAO) were studied in renal tubular cells in conditions of overall FABP inhibition with BMS309403. In these conditions, lipid trafficking was addressed by oil red content and pulse-chase assays using the fluorescent lipid RedC12. Delivery of RedC12 within LD or mitochondria was followed with BODIPY493/503 and Mitotracker and confocal microscopy. Free and esterified RedC12 species were assessed by thin-layer chromatography (TLC). The impact of ATGL lipase activity on cellular behaviour and bioenergetics were assessed by diethylumbelliferyl phosphate (DEUP)-mediated inhibition. Results Kidneys from mice with AKI exhibited early lowered FABPs tubular expression. In serum-depleted murine tubular cells, pharmacological FABPs inhibition with BM309403 (BMS) led to sudden necrosis, whereas, in non-depleted cells, BMS eventually leads to apoptosis, increased the mRNA expression of proinflammatory cytokines and oxidative stress-responsive genes, and restrained proliferation. BMS also rapidly decreased ATP levels consistent with FAO inhibition and induced adaptive AMPK phosphorylation/activation and FAO gene program (but not glycolytic gene expression). BMS also mediates mitochondrial depolarization, mitochondrial oxidative stress and decrease of mitochondria number. Serum-depleted cells revealed lipid droplet (LD) voiding and RedC12 delivery to mitochondria. By contrast, in BMS-treated cells growing in serum, despite the lowered ATP content and transcriptional FAO upregulation, RedC12 neither localized with LDs nor with mitochondria, suggesting a low-energy state by impairment of both lipid transit and FAO. Accordingly, TLC assessment did not show lipid breakdown-derived products, which otherwise did appear in serum-depleted cells doing FAO. Mechanistically, ATGL inhibition protects from general ROS production, LD voiding and apoptosis. Conclusion In brief, FABP inhibition disrupts tubular energetic status and favours cell stress. Thus, protecting FABP activity could help to preserve tubular metabolic homeostasis during early kidney damage.

Genetic Inhibition of FABP4 Attenuated Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in Rhabdomyolysis-Induced Acute Kidney Injury

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Renal Ischemia-Reperfusion Injury

Genetic and Pharmacological Inhibition of Fatty Acid-Binding Protein 4 Alleviated Inflammation and Early Fibrosis after Toxin Induced Kidney Injury.

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 Alleviated Kidney Inflammation and Fibrosis in Hyperuricemic Nephropathy

Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition.

Fatty Acid-Binding Protein 4 is a Therapeutic Target for Septic Acute Kidney Injury by Regulating Inflammatory Response and Cell Apoptosis

#5666 FATTY ACID BINDING PROTEINS (FABPS) INHIBITION IMPAIRS METABOLIC HOMEOSTASIS IN RENAL TUBULAR CELLS

#2743 Impact of fatty acid-binding protein 4 on SUMOylation balance and renal tubular epithelial cell senescence in acute kidney injury

Pre-emptive pharmacological inhibition of fatty acid–binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism

Fatty Acid-Binding Protein 4 in Kidney Diseases: from Mechanisms to Clinics.

Pharmacological and Genetic Inhibition of Fatty Acid-Binding Protein 4 Alleviated Cisplatin-Induced Acute Kidney Injury

Fatty Acid Binding Protein-4 Silencing Inhibits Ferroptosis to Alleviate Lipopolysaccharide-induced Injury of Renal Tubular Epithelial Cells by Blocking Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice.

Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury

Fatty Acid Binding Protein-4 (FABP4) is a Hypoxia Inducible Gene That Sensitizes Mice to Liver Ischemia/reperfusion Injury

FABP4 silencing ameliorates hypoxia reoxygenation injury through the attenuation of endoplasmic reticulum stress-mediated apoptosis by activating PI3K/Akt pathway

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation

MicroRNA-216a-5p Alleviates Acute Kidney Injury of Mice via Suppressing FAS Ligand Expression

Abstract 10460: Urinary Fatty Acid Binding Protein 1 is a Biomarker for Impaired Proximal Tubular Protein Reabsorption and is Synergistically Enhanced by Concurrent Liver Injury

Pifithrin-α ameliorates glycerol induced rhabdomyolysis and acute kidney injury by reducing p53 activation